PLXP stock forecast
Our latest prediction for PLx Pharma, Inc.'s stock price was made on the Dec. 27, 2018 when the stock price was at 1.26$.
In the short term (2weeks), PLXP's stock price should outperform the market by 7.57%. During that period the price should oscillate between -9.74% and +26.05%.
In the medium term (3months), PLXP's stock price should outperform the market by 17.07%. During that period the price should oscillate between -20.89% and +67.55%.Get email alerts
About PLx Pharma, Inc.
PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development of clinically validated and patent-protected PLxGuard delivery system. Its products include Vazalore 325 mg and PL1200 Ibuprofen 200 mg. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Houston, TX.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -3.18$ per share.
The book value per share is 0.75$
Three months stock forecastDec. 27, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|